Source:http://linkedlifedata.com/resource/pubmed/id/18992209
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-2
|
pubmed:abstractText |
The effects of amodiaquine, artesunate and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia (PfMAA) and the recovery from PfMAA were evaluated in 328 children with uncomplicated malaria randomized to the standard dose regimens of the three drug treatments. Overall, malaria-attributable fall in haematocrit (MAFH) before treatment was 4.8+/-2.8%, 95% confidence interval (CI) 4.4-5.2%, and was not significantly different between the treatment groups (P=0.31). An age <5 years and a history of illness >3d were independent predictors of MAFH before treatment >4%. Following treatment, drug-attributable fall in haematocrit (DAFH) was significantly higher in amodiaquine-treated children (4.6+/-2.9%, 2.8+/-1.8%, 3.0+/-1.8% for amodiaquine, artesunate, artesunate-amodiaquine, respectively, P<0.0001). The rate of DAFH was significantly lower in artesunate-treated children (1.4+/-0.9%, 0.7+/-0.6%, 1.0+/-0.6% per day for amodiaquine, artesunate and artesunate-amodiaquine, respectively, P<0.0001). The rate of rise in haematocrit from the nadir on days 3-7 was significantly higher in amodiaquine treated children (P=0.045). In anaemic children (n=68), the time elapsing from treatment to the attainment of a haematocrit > or =30%, the anaemia resolution time, and the proportion of anaemic children with complete resolution on day 14 were similar in all treatment groups (P=0.17 and 0.65, respectively). Artemisinin drugs may reduce the extent and rate of fall in PfMAA during treatment and may attenuate malaria-associated anaemia in children.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amodiaquine,
http://linkedlifedata.com/resource/pubmed/chemical/Antimalarials,
http://linkedlifedata.com/resource/pubmed/chemical/Artemisinins,
http://linkedlifedata.com/resource/pubmed/chemical/artemisinine,
http://linkedlifedata.com/resource/pubmed/chemical/artesunate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1873-6254
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
109
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
55-60
|
pubmed:meshHeading |
pubmed-meshheading:18992209-Amodiaquine,
pubmed-meshheading:18992209-Anemia,
pubmed-meshheading:18992209-Animals,
pubmed-meshheading:18992209-Antimalarials,
pubmed-meshheading:18992209-Artemisinins,
pubmed-meshheading:18992209-Child,
pubmed-meshheading:18992209-Child, Preschool,
pubmed-meshheading:18992209-Drug Therapy, Combination,
pubmed-meshheading:18992209-Female,
pubmed-meshheading:18992209-Humans,
pubmed-meshheading:18992209-Infant,
pubmed-meshheading:18992209-Malaria, Falciparum,
pubmed-meshheading:18992209-Male,
pubmed-meshheading:18992209-Nigeria,
pubmed-meshheading:18992209-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children.
|
pubmed:affiliation |
Department of Pharmacology & Therapeutics and Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria. akinsowunmi@hotmail.com
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|